1. Kang MI, Koh JM, Kim T, et al. Physician's guide for diagnosis & treatment of osteoporosis. Seoul: Korean Society for Bone and Mineral Research;2008.
2. Cummings SR, Black DM, Nevitt MC, et al. The Study of Osteoporotic Fractures Research Group. Appendicular bone density and age predict hip fracture in women. JAMA. 1990; 263:665–668.
Article
3. Yirmiya R, Bab I. Major depression is a risk factor for low bone mineral density: a meta-analysis. Biol Psychiatry. 2009; 66:423–432.
Article
4. Richards JB, Papaioannou A, Adachi JD, et al. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med. 2007; 167:188–194.
Article
5. Pacher P, Ungvari Z, Kecskemeti V, et al. Serotonin reuptake inhibitor, fluoxetine, dilates isolated skeletal muscle arterioles. Possible role of altered Ca2+ sensitivity. Br J Pharmacol. 1999; 127:740–746.
Article
6. Ungvari Z, Pacher P, Kecskeméti V, et al. Fluoxetine dilates isolated small cerebral arteries of rats and attenuates constrictions to serotonin, norepinephrine, and a voltage-dependent Ca (2+) channel opener. Stroke. 1999; 30:1949–1954.
Article
7. Cherin P, Colvez A, Deville de Periere G, et al. Risk of syncope in the elderly and consumption of drugs: a case-control study. J Clin Epidemiol. 1997; 50:313–320.
Article
8. Vaswani M, Linda FK, Ramesh S. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry. 2003; 27:85–102.
Article
9. Ministry of Health & Welfare. Korea Centers for Disease Control and Prevention. Korea health statistics 2009: Korea national health and nutrition examination survey (KNHANESIV-3). Seoul: Ministry of Health & Welfare;2010.
10. Haney EM, Chan BK, Diem SJ, et al. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med. 2007; 167:1246–1251.
Article
11. Yadav VK, Ryu JH, Suda N, et al. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell. 2008; 135:825–837.
Article
12. Ohayon MM, Hong SC. Prevalence of major depressive disorder in the general population of South Korea. J Psychiatr Res. 2006; 40:30–36.
Article
13. MacGillivray S, Arroll B, Hatcher S, et al. Efficacy and tolerability of selective serotonin reuptake inhibitors compared with tricyclic antidepressants in depression treated in primary care: systematic review and meta-analysis. BMJ. 2003; 326:1014.
Article
14. Anderson IM, Tomenson BM. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. BMJ. 1995; 310:1433–1438.
Article
15. Barbui C, Hotopf M, Freemantle N, et al. Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence. Cochrane Database Syst Rev. 2000; 4:CD002791.